首页> 外国专利> The method of monitoring the medicine effectiveness in the diabetes patient who uses the assay concerning 1,5 un hydro D glucitol

The method of monitoring the medicine effectiveness in the diabetes patient who uses the assay concerning 1,5 un hydro D glucitol

机译:使用有关1,5 unhydro D葡萄糖醇的检测方法来监测糖尿病患者药效的方法

摘要

HbA1c measurement is the element which is indispensable to diabetes management, but the important restriction of HbA1c as a measurement method of the blood glucose is lack of timeliness, (as for that, from the fact that it is measurement of average glucose level concerning the long period of time, the diabetes patient who is managed appropriately (HbA1c8) it does not detect the latent blood glucose fluctuation level in). HbA1c from 2 concerning 3 months low averages the both of the blood glucose symptom and the high blood glucose symptom, therefore in the high blood glucose symptom after the food, does not reflect improvement appropriately. Also 1,5 AG, is the marker of blood glucose management concerning the brief framework 2 weeks from 1, but HbA1c it possesses the mechanism which differs. 1,5 AG peculiarity from biological and physiology feature, that is a sensitivity in the high blood glucose episode of acuteness and temporariness, therefore, it is the index whose glucose fluctuation is better. The peptide characteristic diabetes medicine of puramurinchido and ekusenachido etc has peculiar action mechanism, the blood glucose effect of these medicines is not shown appropriately depending upon HbA1c. 1,5 AG which is effective measurement method of glucose fluctuation makes the latent curative effect of these medicines clear, it is possible at the same time to help the adjustment of those dosages.
机译:HbA1c的测定是糖尿病管理中必不可少的要素,但是作为血糖的测定方法,HbA1c的重要限制是缺乏及时性(为此,从长远来看,这是平均葡萄糖水平的测定。在一段时间内,如果对糖尿病患者进行适当管理(HbA1c <8),则不会检测到潜在的血糖波动水平。 HbA1c来自2到3个月低位的平均血糖症状和高血糖症状,因此在进食后的高血糖症状中,不能适当反映出改善。 1,5 AG,也是从1到2周的短暂框架内血糖管理的标志,但是HbA1c具有不同的机制。 1,5 AG具有独特的生物学和生理学特征,即对高血糖发作的急性和暂时性敏感,因此,它是血糖波动较好的指标。 puramurinchido和ekusenachido等具有肽特征的糖尿病药物具有独特的作用机制,这些药物的血糖作用不能根据HbA1c适当显示。 1,5 AG是一种有效的血糖波动测量方法,可以使这些药物的潜在疗效明确,同时可以帮助调整这些剂量。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号